BNTX has terminated a bunch of trials too. You see what they were doing? They enrolled patients and ran the trials. If the results were not good, they just terminated them with no need releasing any PR.
Safety, Tolerability, and Efficacy of mFOLFIRINOX ± BNT321 as Adjuvant Therapy Following Curative Resection in Patients With Pancreatic Adenocarcinoma ClinicalTrials.gov ID NCT06069778 https://clinicaltrials.gov/study/NCT06069778
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors https://clinicaltrials.gov/study/NCT04683939
A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT03871348